Agnes I. Veldkamp

1.2k citations

27 papers · 943 indexed · h-index 17

Infectious Diseases top 2%
Virology top 1%
Epidemiology
Pediatrics, Perinatology and Child Health top 10%
Emergency Medicine top 5%

Co-authors: Richard M. W. Hoetelmans Jos H. Beijnen Joep M. A. Lange Jan W. Mulder Pieter L. Meenhorst Rolf P. G. van Heeswijk Peter Reiss Julio Montaner
Topics: HIV/AIDS drug development and treatment (17 papers)HIV Research and Treatment (15 papers)HIV-related health complications and treatments (8 papers)
Cited by: Virology Infectious Diseases Transplantation
Journals: SHILAP Revista de lepidopterologíaClinical Infectious Diseases The Journal of Infectious Diseases
Partner nations: Netherlands United States Canada

In The Last Decade

Agnes I. Veldkamp

26 papers receiving 900 citations

Peers

Countries citing papers authored by Agnes I. Veldkamp

Since Specialization

Citations

This map shows the geographic impact of Agnes I. Veldkamp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Agnes I. Veldkamp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Agnes I. Veldkamp more than expected).

Fields of papers citing papers by Agnes I. Veldkamp

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Agnes I. Veldkamp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Agnes I. Veldkamp. The network helps show where Agnes I. Veldkamp may publish in the future.

Co-authorship network of co-authors of Agnes I. Veldkamp

This figure shows the co-authorship network connecting the top 25 collaborators of Agnes I. Veldkamp. A scholar is included among the top collaborators of Agnes I. Veldkamp based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Agnes I. Veldkamp. Agnes I. Veldkamp is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimizing Antiviral Dosing for HSV and CMV Treatment in Immunocompromised Patients 2023 ·Pharmaceutics ·(unknown),(unknown),(unknown),(unknown),Paul Elbers,Matthijs R. A. Welkers,Agnes I. Veldkamp,(unknown),David C. de Leeuw,H. Abdullah-Koolmees,Maria T. Kuipers,Imke H. Bartelink	15
2	Predicting treatment response to vancomycin using bacterial DNA load as a pharmacodynamic marker in premature and very low birth weight neonates: A population PKPD study 2023 ·Frontiers in Pharmacology ·(unknown),(unknown),(unknown),(unknown),Martine P. Bos,(unknown),Agnes I. Veldkamp,(unknown),Timo R. de Haan,Yuma A. Bijleveld,(unknown),Paul H. M. Savelkoul,(unknown),Ron A. A. Mathôt,Mirjam M. van Weissenbruch	1
3	An UPLC–MS Detection Method for The Quantification of Five Antibiotics in Human Plasma 2015 ·Bioanalysis ·(unknown),(unknown),René Vos,(unknown),(unknown),Abraham J. Wilhelm,Agnes I. Veldkamp,Eleonora L. Swart,Mirjam M. van Weissenbruch	11
4	Clinical Validation of Dried Blood Spot Sampling in Therapeutic Drug Monitoring of Ciclosporin A in Allogeneic Stem Cell Transplant Recipients 2013 ·Therapeutic Drug Monitoring ·Abraham J. Wilhelm,(unknown),Jeroen C. G. den Burger,Otto Visser,Agnes I. Veldkamp,Jeroen J. W. M. Janssen,Eleonora L. Swart	31
5	Rapid Quantification of Gabapentin, Pregabalin, and Vigabatrin in Human Serum by Ultraperformance Liquid Chromatography With Mass-Spectrometric Detection 2012 ·Therapeutic Drug Monitoring ·(unknown),Arno Sinjewel,Jeroen C. G. den Burger,René Vos,Abraham J. Wilhelm,Agnes I. Veldkamp,Eleonora L. Swart	29
6	Population pharmacokinetics of ciclosporin in haematopoietic allogeneic stem cell transplantation with emphasis on limited sampling strategy 2011 ·British Journal of Clinical Pharmacology ·Abraham J. Wilhelm,Peer de Graaf,Agnes I. Veldkamp,Jeroen J. W. M. Janssen,Peter C. Huijgens,Eleonora L. Swart	30
7	Limited stability of thiopurine metabolites in blood samples: Relevant in research and clinical practise 2010 ·Journal of Chromatography B ·Peer de Graaf,René Vos,Nanne K.H. de Boer,Arno Sinjewel,Bindia Jharap,Chris J. Mulder,Adriaan A. van Bodegraven,Agnes I. Veldkamp	25
8	On Therapeutic Drug Monitoring of Thiopurines in Inflammatory Bowel Disease; Pharmacology, Pharmacogenomics, Drug Intolerance and Clinical Relevance 2009 ·Current Drug Metabolism ·(unknown),Nanne K.H. de Boer,Godefridus J. Peters,Agnes I. Veldkamp,Chris J. Mulder,A Van Bodegraven	40
9	HEPATOTOXICITY FOLLOWING NEVIRAPINE-CONTAINING REGIMENS IN HIV-1-INFECTED INDIVIDUALS 2002 ·Pharmacological Research ·Monique M. R. de Maat,Ron A. A. Mathôt,Agnes I. Veldkamp,Alwin D. R. Huitema,Jan W. Mulder,Pieter L. Meenhorst,Eric C. M. Van Gorp,Hilde Carlier,Jos H. Beijnen	36
10	Steady-State Pharmacokinetics of Twice-Daily Dosing of Saquinavir Plus Ritonavir in HIV-1–Infected Individuals 2001 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Agnes I. Veldkamp,(unknown),Jan W. Mulder,P. L. Meenhorst,Gerrit Schreij,Sjaak van der Geest,Joep M. A. Lange,Jos H. Beijnen,Richard M. W. Hoetelmans	42
11	Limited Sampling Strategies for the Estimation of the Systemic Exposure to the HIV-1 Nonnucleoside Reverse Transcriptase Inhibitor Nevirapine 2001 ·Therapeutic Drug Monitoring ·Agnes I. Veldkamp,Rolf P. G. van Heeswijk,Jan W. Mulder,Pieter L. Meenhorst,Richard M. W. Hoetelmans,Joep MA Lange,Jos H. Beijnen	23
12	Saliva as an Alternative Body Fluid for Therapeutic Drug Monitoring of the Nonnucleoside Reverse Transcription Inhibitor Nevirapine 2001 ·Therapeutic Drug Monitoring ·(unknown),Agnes I. Veldkamp,Jan‐Willem Mulder,Pieter L. Meenhorst,Jos H. Beijnen,Joep M. A. Lange,Richard M. W. Hoetelmans	25
13	The Steady‐State Pharmacokinetics of Efavirenz and Nevirapine When Used in Combination in Human Immunodeficiency Virus Type 1–Infected Persons 2001 ·The Journal of Infectious Diseases ·Agnes I. Veldkamp,Marianne Harris,Julio Montaner,Graeme Moyle,(unknown),Mike Youle,M Johnson,(unknown),Hilde Carlier,Remko van Leeuwen,Jos H. Beijnen,Joep MA Lange,Peter Reiss,Richard M. W. Hoetelmans	43
14	The steady-state pharmacokinetics of nevirapine during once daily and twice daily dosing in HIV-1-infected individuals 2000 ·AIDS ·Rolf P. G. van Heeswijk,Agnes I. Veldkamp,Jan W. Mulder,Pieter L. Meenhorst,Ferdinand W.N.M. Wit,Joep M. A. Lange,Sven A. Danner,Norbert A. Foudraine,(unknown),Peter Reiss,Jos H. Beijnen,Richard M. W. Hoetelmans	113
15	Once-daily dosing of saquinavir and low-dose ritonavir in HIV-1-infected individuals: a pharmacokinetic pilot study 2000 ·AIDS ·Rolf P. G. van Heeswijk,Agnes I. Veldkamp,Jan W. Mulder,Pieter L. Meenhorst,Joep M. A. Lange,Jos H. Beijnen,Richard M. W. Hoetelmans	39
16	Rapid quantification of delavirdine, a novel non-nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with fluorescence detection 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·Agnes I. Veldkamp,Rolf P. G. van Heeswijk,Richard M. W. Hoetelmans,Pieter L. Meenhorst,Jan W. Mulder,J Lange,J. H. Beijnen	7
17	Quantitative determination of abacavir (1592U89), a novel nucleoside reverse transcriptase inhibitor, in human plasma using isocratic reversed-phase high-performance liquid chromatography with ultraviolet detection 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·Agnes I. Veldkamp,Rolf W. Sparidans,Richard M. W. Hoetelmans,J. H. Beijnen	21
18	Ritonavir Enables Combined Therapy with Rifampin and Saquinavir 1999 ·Clinical Infectious Diseases ·Agnes I. Veldkamp,Richard M. W. Hoetelmans,J. H. Beijnen,Jan W. Mulder,P. L. Meenhorst	49
19	Improved and simplified liquid chromatographic assay for adefovir, a novel antiviral drug, in human plasma using derivatization with chloroacetaldehyde 1999 ·Journal of Chromatography B Biomedical Sciences and Applications ·Rolf W. Sparidans,Agnes I. Veldkamp,Richard M. W. Hoetelmans,J. H. Beijnen	16
20	The steady-state plasma pharmacokinetics of indinavir alone and in combination with a low dose of ritonavir in twice daily dosing regimens in HIV-1-infected individuals 1999 ·AIDS ·Rolf P. G. van Heeswijk,Agnes I. Veldkamp,Richard M. W. Hoetelmans,Jan W. Mulder,Gerrit Schreij,Ann Hsu,Joep M. A. Lange,Jos H. Beijnen,Pieter L. Meenhorst	95

About Agnes I. Veldkamp

Agnes I. Veldkamp is a scholar working on Virology, Infectious Diseases and Emergency Medicine, having authored 27 papers that have together received 943 indexed citations. Recurring topics across this work include HIV/AIDS drug development and treatment (17 papers), HIV Research and Treatment (15 papers) and HIV-related health complications and treatments (8 papers). The work is most often cited by research in Virology (510 citations), Infectious Diseases (697 citations) and Transplantation (43 citations). Agnes I. Veldkamp has collaborated with scholars based in Netherlands, United States and Canada. Frequent co-authors include Richard M. W. Hoetelmans, Jos H. Beijnen, Joep M. A. Lange, Jan W. Mulder, Pieter L. Meenhorst, Rolf P. G. van Heeswijk, Peter Reiss, Julio Montaner, David A. Cooper and Gerrit Jan Weverling. Their work appears in journals such as SHILAP Revista de lepidopterología, Clinical Infectious Diseases and The Journal of Infectious Diseases.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact